PAMS
Pictet Asset Management (Switzerland)’s Sarepta Therapeutics SRPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $109M | Sell |
953,003
-260,353
| -21% | -$29.8M | 0.13% | 186 |
|
|
2023
Q1 | $167M | Buy |
1,213,356
+282,713
| +30% | +$39M | 0.21% | 140 |
|
|
2022
Q4 | $121M | Buy |
930,643
+263,599
| +40% | +$34.2M | 0.17% | 164 |
|
|
2022
Q3 | $73.7M | Buy |
667,044
+547,857
| +460% | +$60.6M | 0.11% | 221 |
|
|
2022
Q2 | $8.93M | Buy |
119,187
+31,331
| +36% | +$2.35M | 0.01% | 621 |
|
|
2022
Q1 | $6.86M | Sell |
87,856
-4,286
| -5% | -$335K | 0.01% | 740 |
|
|
2021
Q4 | $8.3M | Buy |
92,142
+11,270
| +14% | +$1.01M | 0.01% | 718 |
|
|
2021
Q3 | $7.48M | Buy |
+80,872
| New | +$7.48M | 0.01% | 752 |
|